Wobenzym N
Natural health product licensed in Canada
- Licence holder
- Mucos Pharma GmbH & Co. KG
- NPN or DIN-HM
- 02136740
- Status
- Inactive licence
- Licence date
- 29 October 2009
- Revision date
- 11 April 2013
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Trypsine Source : Bos taurus (Pancréas Bovin) | 24 mg | Not calculated |
| Trypsine Source : Bos taurus (Pancréas Bovin) | 57,600 unités de trypsine de la USP | Not calculated |
| Trypsine Source : Sus scrofa - pancréas | 24 mg | Not calculated |
| Trypsine Source : Sus scrofa - pancréas | 57,600 unités de trypsine de la USP | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 45 mg | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 1,687,500 FCC PU | Not calculated |
| Enzymes pancréatiques Source : Sus scrofa - pancréas | 100 mg | Not calculated |
| Enzymes pancréatiques Source : Sus scrofa - pancréas | 18,700 Unité d'activité protéase de la USP | Not calculated |
| Enzymes pancréatiques Source : Sus scrofa - pancréas | 18,675 unité d¿activité amylase de la USP | Not calculated |
| Enzymes pancréatiques Source : Sus scrofa - pancréas | 4,000 Unité d'activité lipase de la USP | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Acide stéarique, Ethyl cellulose, silice, Acide oléique, Alginate de sodium, Saveur de vanille naturelle, cellulose, Eau, triglycérides à chaînes moyennes, Hyprolose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Comprimé | 4 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Relieves pain associated with osteoarthritis of the knee and hip; A factor in ankle joint injury recuperation; An antioxidant.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 02136740
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2013. Photograph the packaging to check whether it has changed. Photograph the packaging